Gregory Bailey - Apr 28, 2022 Form 4 Insider Report for Biohaven Pharmaceutical Holding Co Ltd. (BHVN)

Role
Director
Signature
/s/ George Clark, Attorney-in-Fact
Stock symbol
BHVN
Transactions as of
Apr 28, 2022
Transactions value $
$0
Form type
4
Date filed
4/29/2022, 08:59 PM
Previous filing
Jun 23, 2021
Next filing
Aug 22, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BHVN Stock Option (Right to Buy) Award $0 +8.24K $0.00 8.24K Apr 28, 2022 Common Shares 8.24K $97.74 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this stock option will vest in full on the earlier of (a) April 28, 2023 or (b) the date of the 2023 Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date.

Remarks:

Exhibit List: Exhibit 24: Power of attorney